QR-Code

Assessment of Exenatide Extended‐Release for Maintenance of Diabetic Remission in Cats

ABSTRACT Background Insulin‐treated diabetic cats frequently achieve transient remission. The glucagon‐like peptide‐1 receptor agonist, exenatide extended‐release (exenatide‐ER), preserves β cell function in people with type 2 diabetes mellitus (DM). Objectives Investigate the effect of exenatide‐ER...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Chen Gilor, Linda M. Fleeman, Sean E. Hulsebosch, Stijn J. M. Niessen, Charlotte R. Bjørnvad, Jully Pires, Katarina Hazuchova, Jocelyn Mott, Allison L. O'Kell, Ruth Gostelow, Adam J. Rudinsky, Audrey K. Cook
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2025-03-01
Schriftenreihe:Journal of Veterinary Internal Medicine
Schlagworte:
diabetes mellitus
feline
GLP‐1
glucagon
remission
weight loss
Online-Zugang:https://doi.org/10.1111/jvim.70069
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge